Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.342SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.90SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.169SYoung-STATACATGTCTCTGGGACCA20452176321782F-3872.72Singapore
B.53SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.493SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.351.2 (Beta)SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.640.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.352SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.251SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
HC.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XCJSYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FT.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FZ.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FY.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.497SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.355SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
GA.7.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.403SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
A.27SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BQ.1.1.30SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BQ.1.9SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
GW.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.40SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FY.7SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BQ.1.2.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
B.1.1.367SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
GK.1.9SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BN.1.3.13SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.385SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.5.45SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.244SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
JD.2.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
EP.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FL.17.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
EG.12SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
CM.7.1.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FL.10.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FD.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
KG.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.5.13SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
HA.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.351 (Beta)SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.5.36SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
HZ.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.5.30SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FL.19.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FY.5.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FP.2.1.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.2.9SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FL.2.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used